Where this topic shows up
Our markets on alzheimer's, by category.
- Healthcare Services · 1
- Pharmaceuticals · 1
Market reports
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Free public health charts
Live data from public sources. The line shows the world (or US) trend.
Clinical trials: Alzheimer's disease
2011–2025 · trials started
Clinical trials on alzheimer's disease that started each year with at least one site in the place…
Compare placesAlzheimer's disease death rate
2003–2017 · deaths per 100,000 people (age-adjusted)
Deaths from alzheimer's disease for every 100,000 people, adjusted so states with older people can…
Compare placesKey companies
Named as key players in the most of these markets.
AbbVie Inc.2 markets here
Eli Lilly and Company2 markets here
F. Hoffmann-La Roche Ltd2 markets here
AC Immune (Switzerland)1 market here
Accera, Inc.1 market here
Alector, Inc.1 market here
AMARANTUS BIOSCIENCE HOLDINGS, INC.1 market here
Anavex Life Sciences Corp.1 market here
AXON Neuroscience (Slovakia)1 market here
Biogen Inc1 market here
Cognition Therapeutics, Inc.1 market here
Daiichi Sankyo Company, Limited1 market here
All markets on this topic
Each opens the market's statistics page, with every country we cover.
Healthcare Services
Pharmaceuticals
Related topics
Need research on alzheimer's?
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.